Back

Gas Discharge Visualization to Assess Bioenergy for Medical Applications

Principal Investigator: Clair A. Francomano, MD, Chief, Human Genetics and Integrative Medicine, Laboratory of Genetics, National Institute of Aging

Affiliations: National Institutes of Health; Johns Hopkins University

Background: Many systems of healing use the concept of a bioenergy that runs through the human body and plays a pivotal role in an individual’s health. Though there are tools that purport to measure these fields, most data have not been obtained in rigorous scientific fashion or published in international peer-review journals of repute. Clinical studies to evaluate the validity of such devices require clinical facilities and investigators with expertise in the regulatory and design issues inherent in such research. The Gas Discharge Visualization [GDV] instrument was invented by Konstantin Korotkov in 1999. The device is a culmination of previous work that photographs patterns of light coronas in close proximity to objects including humans, with computerized systems for analysis of these discharges. It is now appropriate to evaluate GDV rigorously on human subjects with known medical diagnoses.

Hypotheses: 1) There is an energy field surrounding each human being, which is detectable and quantifiable by existing instruments; 2) alterations in the human energy field correlate with medical diagnoses as established by traditional Western approaches and in some instances predate the medical diagnoses.

Methods and materials: Specific clinical research protocols will be created to test the GDV and determine its correlation with known medical diagnoses. Approvals from Human Use Review Committees and the Food and Drug Administration for conduct of the research will be obtained.

Anticipated results: If successful, this research will demonstrate the first scientifically objective method for directly measuring human bioenergy.

Relationship to SIIB mission and healing: The presence of a human energy field is an essential component of many nonwestern systems of healing. GDV might become a bonafide measurement device of bioenergy, allowing the use of non-molecular non-thermal informational signals in healing. The planned research would meet FDA approval thereby allowing GDV to be used in clinical research studies and eventually clinical practice.
 

 





Funded Research